Mineralys Therapeutics (MLYS) Institutional Ownership → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free MLYS Stock Alerts $13.51 -0.01 (-0.07%) (As of 10:27 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)CurrentInstitutional OwnershipPercentage84.46%Number ofInstitutional Buyers(last 12 months)33TotalInstitutional Inflows(last 12 months)$175.03MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$3.90M Get MLYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MLYS Institutional Buying and Selling by Quarter Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won't be Biden… And it won't be Trump.Click here to see why it will be _______________ Mineralys Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/10/2024Vanguard Group Inc.982,932$12.69M0.0%+0.5%1.980% 4/29/2024 China Universal Asset Management Co. Ltd.7,931$102K0.0%+67.0%0.016% 3/22/2024PNC Financial Services Group Inc.4,122$35K0.0%+17,821.7%0.010% 2/14/2024Catalys Pacific LLC9,194,579$79.07M74.1%N/A22.371% 2/14/2024Pale Fire Capital SE34,743$299K0.0%N/A0.085% 2/14/2024Sectoral Asset Management Inc.605,606$5.21M2.2%-28.0%1.473% Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/13/2024Tower Research Capital LLC TRC 2,879$25K0.0%-71.4%0.007% 2/13/2024NEOS Investment Management LLC23,973$206K0.0%N/A0.058% 2/9/2024Franklin Resources Inc.699,467$6.02M0.0%+55.4%1.702% 2/9/2024CreativeOne Wealth LLC10,750$92K0.0%N/A0.026% 2/7/2024Jump Financial LLC20,500$176K0.0%-37.3%0.050% 2/5/2024 Russell Investments Group Ltd.5,779$50K0.0%-43.2%0.014% 2/1/2024 CWM LLC5,891$51K0.0%+120.0%0.014% 1/31/2024Federated Hermes Inc.20,032$172K0.0%-10.1%0.049% 1/30/2024 Cornercap Investment Counsel Inc.22,209$191K0.0%N/A0.054% 1/24/2024 China Universal Asset Management Co. Ltd.4,750$41K0.0%N/A0.012% 1/16/2024 Raymond James Financial Services Advisors Inc.14,611$126K0.0%-64.0%0.036% 1/12/2024 SG Americas Securities LLC10,093$87K0.0%N/A0.025% 11/15/2023Sectoral Asset Management Inc.840,759$8.00M1.6%+36.8%2.046% 11/15/2023Laurion Capital Management LP969,978$9.22M0.1%+42.6%2.360% 11/14/2023Braidwell LP2,023,900$19.25M0.6%+267.8%4.924% 11/14/2023Schonfeld Strategic Advisors LLC192,362$1.83M0.0%+64.3%0.468% 11/13/2023CHI Advisors LLC568,379$5.41M1.6%N/A1.383% 11/13/2023Federated Hermes Inc.22,293$212K0.0%+8.3%0.054% 11/13/2023FMR LLC1,188,653$11.30M0.0%+62.6%2.892% 11/7/2023Jump Financial LLC32,700$311K0.0%N/A0.080% 10/24/2023 Raymond James Financial Services Advisors Inc.40,578$386K0.0%N/A0.099% 10/11/2023 CWM LLC2,678$25K0.0%N/A0.007% 9/21/2023Barclays PLC2,778$47K0.0%-77.8%0.007% 8/15/2023Sphera Funds Management LTD.405,400$6.91M1.1%+19.6%0.992% 8/14/2023Great Point Partners LLC546,059$9.31M1.8%-12.0%1.336% 8/14/2023Driehaus Capital Management LLC499,983$8.53M0.1%+10.4%1.224% 8/11/2023 Panagora Asset Management Inc.23,016$392K0.0%N/A0.056% 8/11/2023Sectoral Asset Management Inc.614,713$10.48M1.7%+0.2%1.504% 8/11/2023ExodusPoint Capital Management LP193,525$3.30M0.0%+6.7%0.474% 8/10/2023 Letko Brosseau & Associates Inc.11,400$194K0.0%N/A0.028% 8/4/2023American International Group Inc.6,717$115K0.0%+15.0%0.016% 8/2/2023Bank of Montreal Can101,724$1.51M0.0%N/A0.249% 5/19/2023SR One Capital Management LP1,794,600$28.10M9.5%N/A4.392% 5/16/2023Great Point Partners LLC620,326$9.71M1.9%N/A1.518% How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 5/16/2023Ghisallo Capital Management LLC10,000$157K0.0%N/A0.024% 5/15/2023Affinity Asset Advisors LLC62,500$979K0.3%N/A0.153% 5/15/2023Logos Global Management LP300,000$4.70M0.7%N/A0.734% 5/15/2023RTW Investments LP922,100$14.44M0.3%N/A2.257% 5/12/2023Sectoral Asset Management Inc.613,233$9.60M1.8%N/A1.501% 5/11/2023ExodusPoint Capital Management LP181,312$2.84M0.0%N/A0.444% 5/11/2023American Century Companies Inc.417,903$6.53M0.0%N/A1.023% 5/5/2023Monashee Investment Management LLC110,000$1.72M0.5%N/A0.269% 4/27/2023Strs Ohio2,500$39K0.0%N/A0.006% (Data available from 1/1/2016 forward) MLYS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MLYS shares? During the previous two years, 39 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were Catalys Pacific LLC ($79.07M), SR One Capital Management LP ($28.10M), Braidwell LP ($19.25M), RTW Investments LP ($14.44M), Vanguard Group Inc. ($12.69M), FMR LLC ($11.30M), and Great Point Partners LLC ($9.31M).Learn more on MLYS's institutional investors. What percentage of Mineralys Therapeutics stock is owned by institutional investors? 84.46% of Mineralys Therapeutics stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings. Which institutional investors have been buying Mineralys Therapeutics stock? Of the 36 institutional investors that purchased Mineralys Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Catalys Pacific LLC ($9.19M), SR One Capital Management LP ($1.79M), Braidwell LP ($1.47M), RTW Investments LP ($922.10K), Sectoral Asset Management Inc. ($840.76K), Great Point Partners LLC ($620.33K), and CHI Advisors LLC ($568.38K). How much institutional buying is happening at Mineralys Therapeutics? Institutional investors have bought a total of 18,033,150 shares in the last 24 months. This purchase volume represents approximately $195.78M in transactions. Which Mineralys Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Mineralys Therapeutics stock in the last 24 months: Sectoral Asset Management Inc. ($235.15K), Great Point Partners LLC ($74.27K), Raymond James Financial Services Advisors Inc. ($25.97K), Jump Financial LLC ($12.20K), Barclays PLC ($9.76K), Tower Research Capital LLC TRC ($7.18K), and Russell Investments Group Ltd. ($4.40K). How much institutional selling is happening at Mineralys Therapeutics? Institutional investors have sold a total of 371,188 shares in the last 24 months. This volume of shares sold represents approximately $3.90M in transactions. Related Companies: ANAB Institutional Ownership DNTH Institutional Ownership WVE Institutional Ownership NRIX Institutional Ownership NUVB Institutional Ownership BCYC Institutional Ownership SVRA Institutional Ownership PAHC Institutional Ownership IRON Institutional Ownership AUPH Institutional Ownership This page (NASDAQ:MLYS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsNext President (Not Trump. Not Biden.)The Freeport SocietyHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.